Version 139 (modified by Andrew, 5 months ago)



New developments for the MIDAS project will cease as of May 2022. There will still be continued support and the web site and distributions of the updated versions of the EPSI sequence and MIDAS software will be continued for as long as possible, though we may not be able to support custom requests.

Recent Papers

Ahlswede M, et al. Alterations of Striato-Thalamic Metabolism in Normal Aging Human Brain-An MR Metabolic Imaging Study. Metabolites. 2021 Jun 9;11(6):371.

Bustillo JR, et al. Increased glutamate plus glutamine in the right middle cingulate in first episode schizophrenia but not in bipolar psychosis: A whole brain 1H-MRS study. Frontiers Psychiatry, 2021 Jun 7;12:660850.

The MIDAS Project

The MIDAS project is developing and evaluating methods for Magnetic Resonance Spectroscopic Imaging (MRSI) for clinical research studies. This includes development of the MIDAS software (Metabolite Imaging and Data Analysis System), which provides an integrated set of MRI and MRSI processing functions for "whole-brain" MRSI.

This project aims to further develop and distribute these capabilities and to encourage more widespread use of MRSI for diagnostic imaging and improved mapping of metabolite distributions in the human brain. More information can be found here.

This project is funded by the National Institute for Biomedical Imaging and Bioengineering, initially under grant R01EB00822 and continued under R01EB016064.


Links on MRI and MRSI

For a list of local wiki pages, see TitleIndex.